Inventor · disambiguated record
Dinesh V. Patel
Also filed as: PATEL DINESH · PATEL DINESH V · PATEL DINESH VINOOBHAI
59 granted patents·19 pending applications·1,434 citations·filing 1987–2023
99Inventor score
Top patents by PatentIndex Score
78 records- 0198US11111272B2α4α7 peptide monomer and dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2020·Granted Sep 7, 2021·10 cites·14 claims
- 0298US10626146B2α4β7 thioether peptide dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2018·Granted Apr 21, 2020·15 cites·22 claims
- 0398US9518091B2A4B7 peptide monomer and dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2016·Granted Dec 13, 2016·34 cites·21 claims
- 0498US5523430AProtein farnesyl transferase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Jun 4, 1996·171 cites·12 claims
- 0597US10941183B2Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseasesPROTAGONIST THERAPEUTICS INC·Filed 2018·Granted Mar 9, 2021·13 cites·20 claims
- 0697US10301371B2Cyclic monomer and dimer peptides having integrin antagonist activityPROTAGONIST THERAPEUTICS INC·Filed 2015·Granted May 28, 2019·19 cites·14 claims
- 0797US10196424B2Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseasesPROTAGONIST THERAPEUTICS INC·Filed 2017·Granted Feb 5, 2019·26 cites·22 claims
- 0897US10059744B2α4β7 thioether peptide dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2017·Granted Aug 28, 2018·22 cites·31 claims
- 0997US10035824B2Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseasesPROTAGONIST THERAPEUTICS INC·Filed 2017·Granted Jul 31, 2018·24 cites·26 claims
- 1097US10023614B2Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseasesPROTAGONIST THERAPEUTICS INC·Filed 2017·Granted Jul 17, 2018·23 cites·21 claims
- 1197US9809623B2α4β7 peptide monomer and dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2015·Granted Nov 7, 2017·26 cites·14 claims
- 1297US9714270B2a4B7 integrin thioether peptide antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2015·Granted Jul 25, 2017·27 cites·22 claims
- 1397US9624268B2Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseasesPROTAGONIST THERAPEUTICS INC·Filed 2015·Granted Apr 18, 2017·40 cites·24 claims
- 1497US5510510AInhibitors of farnesyl protein transferaseBRISTOL MEYERS SQUIBB CO·Filed 1994·Granted Apr 23, 1996·135 cites·7 claims
- 1596US5932579ACollagenase-1 and stromelysin-1 inhibitors, pharmaceutical compositions comprising same and methods of their useAFFYMAX TECH NV·Filed 1996·Granted Aug 3, 1999·97 cites·13 claims
- 1695US9273093B2α4β7 peptide dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2013·Granted Mar 1, 2016·31 cites·8 claims
- 1793US10787490B2Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseasesPROTAGONIST THERAPEUTICS INC·Filed 2016·Granted Sep 29, 2020·18 cites·18 claims
- 1893US7371875B2Cytotoxic agents and methods of useMIIKANA THERAPEUTICS INC·Filed 2005·Granted May 13, 2008·30 cites·17 claims
- 1991US10407468B2Methods for synthesizing α4β7 peptide antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2017·Granted Sep 10, 2019·13 cites·24 claims
- 2090US7772245B2Inhibitors of histone deacetylaseMIIKANA THERAPEUTICS INC·Filed 2006·Granted Aug 10, 2010·10 cites·8 claims
- 2190US7345043B2Inhibitors of histone deacetylaseMIIKANA THERAPEUTICS·Filed 2005·Granted Mar 18, 2008·27 cites·19 claims
- 2290US6239152B1Oxazolidinone combinatorial libraries, compositions and methods of preparationUPJOHN CO·Filed 1999·Granted May 29, 2001·83 cites·37 claims
- 2390US6025371ASolid phase and combinatorial library syntheses of fused 2,4-pyrimidinedionesVERSICOR INC·Filed 1996·Granted Feb 15, 2000·57 cites·6 claims
- 2490US5990112AInhibitors of metalloproteases pharmaceutical compositions comprising same and methods of their useAFFYMAX TECH NV·Filed 1996·Granted Nov 23, 1999·73 cites·5 claims
- 2589US6869965B2Antimicrobial quinolone derivatives and use of the same to treat bacterial infectionsUPJOHN CO·Filed 2003·Granted Mar 22, 2005·27 cites·5 claims
- 2689US6689769B2Antimicrobial quinolone derivatives and use of the same to treat bacterial infectionsUPJOHN CO·Filed 2001·Granted Feb 10, 2004·36 cites·15 claims
- 2789US6531470B1Oxazolidinone combinatorial libraries, compositions and methods of preparationUPJOHN CO·Filed 2000·Granted Mar 11, 2003·36 cites·7 claims
- 2888US11840581B2α4β7 thioether peptide dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2020·Granted Dec 12, 2023·1 cites·17 claims
- 2988US6562844B2Oxazolidinone combinatorial libraries, compositions and methods of preparationUPJOHN CO·Filed 2001·Granted May 13, 2003·23 cites·46 claims
- 3088US6441005B1Oxazolidinone compounds and compositions, and methods of using the sameUPJOHN CO·Filed 2000·Granted Aug 27, 2002·27 cites·60 claims
- 3188US5840698AInhibitors of collagenase-1 and stormelysin-I metalloproteases, pharmaceutical compositions comprising same and methods of their useAFFYMAX TECH NV·Filed 1995·Granted Nov 24, 1998·37 cites·14 claims
- 3288US2024199700A1Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseasesPROTAGONIST THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3387US6797820B2Succinate compounds, compositions and methods of use and preparationVICURON PHARM INC·Filed 2000·Granted Sep 28, 2004·23 cites·48 claims
- 3486US6987104B2Pyrrolidine bicyclic compounds and its derivatives, compositions and methods of useVICURON PHARM INC·Filed 2002·Granted Jan 17, 2006·12 cites·36 claims
- 3586US2024209026A1A4b7 thioether peptide dimer antagonistsPROTAGONIST THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3685US6852752B2Urea compounds, compositions and methods of use and preparationVICURON PHARM INC·Filed 2000·Granted Feb 8, 2005·17 cites·26 claims
- 3783US5217958A1,2-hydroxy phosphonates and derivatives thereofSQUIBB & SONS INC·Filed 1990·Granted Jun 8, 1993·25 cites·6 claims
- 3880US8153630B2Kinase inhibitorsXIAO XIAO-YI·Filed 2005·Granted Apr 10, 2012·4 cites·12 claims
- 3978US7148242B2N-formyl hydroxylamine compounds, compositions and methods of useNOVARTIS AG·Filed 2002·Granted Dec 12, 2006·11 cites·40 claims
- 4077US7199105B2Lincomycin derivatives possessing antibacterial activityVICURON PHARM INC·Filed 2004·Granted Apr 3, 2007·8 cites·29 claims
- 4177US7164011B2Lincomycin derivatives possessing antibacterial activityVICURON PHARM INC·Filed 2003·Granted Jan 16, 2007·8 cites·29 claims
- 4276US11884748B2Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseasesPROTAGONIST THERAPEUTICS INC·Filed 2021·Granted Jan 30, 2024·0 cites·21 claims
- 4376US5929278AInhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their useAFFYMAX TECH NV·Filed 1998·Granted Jul 27, 1999·12 cites·8 claims
- 4475US7691843B2N-hydroxyamide derivatives possessing antibacterial activityPFIZER·Filed 2003·Granted Apr 6, 2010·9 cites·23 claims
- 4575US6281245B1Methods for solid-phase synthesis of hydroxylamine compounds and derivatives, and combinatorial libraries thereofVERSICOR INC·Filed 1998·Granted Aug 28, 2001·28 cites·27 claims
- 4675US2022162261A1NOVEL a4B7 PEPTIDE MONOMER AND DIMER ANTAGONISTSPROTAGONIST THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4772US2020239523A1NOVEL a4B7 THIOETHER PEPTIDE DIMER ANTAGONISTSPROTAGONIST THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4870US6307101B1Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their useFiled 1999·Granted Oct 23, 2001·9 cites·4 claims
- 4967US5831004AInhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their useAFFYMAX TECH NV·Filed 1995·Granted Nov 3, 1998·13 cites·8 claims
- 5066US7105547B2Antimicrobial 1-aryl dihydropyridone compoundsUPJOHN CO·Filed 2003·Granted Sep 12, 2006·3 cites·11 claims
Showing the top 50 of 78 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Dinesh V. Patel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →